Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells.
Michaelis M, Rothweiler F, Barth S, Cinatl J, van Rikxoort M, Löschmann N, Voges Y, Breitling R, von Deimling A, Rödel F, Weber K, Fehse B, Mack E, Stiewe T, Doerr HW, Speidel D, Cinatl J Jr.
Michaelis M, et al. Among authors: weber k.
Cell Death Dis. 2011 Dec 15;2(12):e243. doi: 10.1038/cddis.2011.129.
Cell Death Dis. 2011.
PMID: 22170099
Free PMC article.